Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;9(7):1533-9.
doi: 10.1074/mcp.M900508-MCP200. Epub 2010 Jan 15.

Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells

Affiliations

Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells

Susana Infantes et al. Mol Cell Proteomics. 2010 Jul.

Abstract

Cytotoxic T lymphocyte (CTL)-mediated death of virus-infected cells requires prior recognition of short viral peptide antigens that are presented by human leukocyte antigen (HLA) class I molecules on the surface of infected cells. The CTL response is critical for the clearance of human respiratory syncytial virus (HRSV) infection. Using mass spectrometry analysis of complex HLA-bound peptide pools isolated from large amounts of HRSV-infected cells, we identified nine naturally processed HLA-B27 ligands. The isolated peptides are derived from six internal, not envelope, proteins of the infective virus. The sequences of most of these ligands are not conserved between different HRSV strains, suggesting a mechanism to explain recurrent infection with virus of different HRSV antigenic subgroups. In addition, these nine ligands represent a significant fraction of the proteome of this virus, which is monitored by the same HLA class I allele. These data have implications for vaccine development as well as for analysis of the CTL response.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Identification of the N 100–109 ligand in infected cell extracts by mass spectrometry. MS/MS fragmentation spectra obtained from quadrupole ion trap mass spectrometry of the ion peaks at m/z 614.3 (upper panel) and m/z 409.9 (lower panel) from the HRSV-infected B27-C1R cell extract are shown. The vertical axis represents the relative abundance of the parental ion and each fragmentation ion detected. The horizontal axis corresponds to the m/z region in which significant daughter ions were detected. Ions generated in the fragmentation are detailed, and the sequence deduced from the indicated fragments is shown in the upper right box of each panel.
Fig. 2.
Fig. 2.
HLA stabilization assay of HRSV synthetic ligands. The stability of HLA-B*2705-peptide complexes on the surface of RMA-S transfectant cells was measured by flow cytometry. The indicated peptides were used at 200 μm. The C4CON (38) and Flu NP (37) peptides were used as negative and positive controls, respectively. The results, calculated as fluorescence index (see “Experimental Procedures”), are the mean (bars) ± S.D. (error bars) of three to four independent experiments.

Similar articles

Cited by

References

    1. Shastri N., Schwab S., Serwold T. (2002) Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20, 463–493 - PubMed
    1. Del-Val M., López D. (2002) Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8+ T lymphocytes. Mol. Immunol. 39, 235–247 - PubMed
    1. Parker K. C., Bednarek M. A., Coligan J. E. (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163–175 - PubMed
    1. Rammensee H., Bachmann J., Emmerich N. P., Bachor O. A., Stevanoviæ S. (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213–219 - PubMed
    1. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506–512 - PubMed

Publication types

MeSH terms